Cognitive testing in the context of Alzheimer's Disease and dementia is crucial for early detection and monitoring of cognitive decline. These tests assess various cognitive functions such as memory, attention, language abilities, and problem-solving skills. They help clinicians establish a baseline of cognitive function, track changes over time, and differentiate between normal aging and pathological conditions like Alzheimer's.
Commonly used tests include the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Clock Drawing Test. These assessments provide valuable insights into a person's cognitive abilities and help in formulating personalized care plans. Early identification through cognitive testing allows for timely interventions, potentially slowing down cognitive decline and improving quality of life. Regular monitoring with these tests is essential for adapting care strategies as the disease progresses.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States